⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3963314 | 1.00 | — | — | |
| SCHEMBL11631041 | 1.00 | — | — | |
| SCHEMBL28173408 | 1.00 | — | — | |
| SCHEMBL7068760 | 1.00 | — | — | |
| SCHEMBL11633001 | 1.00 | — | — | |
| SCHEMBL10388761 | 1.00 | — | — | |
| SCHEMBL11629843 | 1.00 | — | — | |
| Fluoride SCHEMBL23065011 | 0.82 | — | — | |
| Iodide SCHEMBL2872084 | 0.82 | — | — | |
| SCHEMBL1361568 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570666-B2 | Furoindazole derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-4077334-B1 | FUROINDAZOLE DERIVATIVES | BAYER AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| US-20230112499-A1 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
| EP-4077334-A1 | FUROINDAZOLE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2022-10-26 | — | — | EP | disclosed |
| WO-2021122415-A9 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-30 | — | — | WO | disclosed |
| US-20220089540-A1 | COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2022-03-24 | — | — | US | disclosed |
| EP-3911309-A1 | COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER | Board Of Trustees Of Michigan State University (US) | 2021-11-24 | — | — | EP | disclosed |
| CN-113621001-A | Organic electroluminescent material and device | 环球展览公司 | 2021-11-09 | — | — | CN | disclosed |
| WO-2021122415-A1 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021033980-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2021-02-25 | — | — | WO | disclosed |
| CN-104445793-B | A kind of method of processing ethylene waste lye up to standard | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | disclosed |
| CN-105593422-A | Fire resistant panel and methods of fire blocking an article | DREAMWELL LTD | 2016-05-18 | — | — | CN | disclosed |
| CN-104194385-B | A kind of azo group 1:2 premetallized dye composition and tint applications thereof | SHANGHAI ARGUS TEXTILE CHEMICAL CO., LTD. (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-103443933-B | Backboard used for solar batteries and manufacture method thereof and solar module | FUJIFILM CORP. (JP) | 2016-05-04 | — | — | CN | disclosed |
| EP-2262795-A1 | MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF | AstraZeneca AB (SE) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009110844-A1 | MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF | ASTRAZENECA AB (SE) | 2009-09-11 | — | — | WO | disclosed |
| US-20090221642-A1 | MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF-176 | ASTRAZENECA AB (SE) | 2009-09-03 | — | — | US | disclosed |
| US-7053099-B1 | 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-30 | — | — | US | disclosed |
| EP-1235814-B1 | 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2004-11-03 | — | — | EP | disclosed |
| US-4053470-A | BACTERICIDES, ANTIBIOTICS | PARKE, DAVIS & COMPANY (US) | 1977-10-11 | — | — | US | disclosed |